4T Medical is proud to announce the launch of the X3M Glow Booster, an intensive correcting and brightening serum which addresses pigmentation and helps to reduce the appearance of dark spots and post-inflammatory acne scars, without the need for a prescription.
Designed to address pigmentation concerns caused by sun exposure, aging, acne, and hormonal changes, the CLINICCARE X3M Glow Booster is a powerful serum formulated with a cutting-edge combination of active ingredients. The formula works to not only correct existing pigmentation but also help prevent future discoloration, resulting in a more even and radiant complexion.
Key ingredients include:
200 mg/ml Low Molecular Weight Hyaluronic Acid (LMWHA) improves hydration and skin elasticity and decreases trans-epidermal water loss (TEWL) and inflammation. Reduces wrinkles and improves wound healing.
30 mg/ml Tranexamic Acid essentially works to lighten hyperpigmentation in two ways – by blocking melanin production, as well as the transfer of melanin to the outer skin layer. Also helps to even skin tone.
10 mg/ml Genowhite: has many positive effects on pigmentation including brightening the skin, reducing the appearance of dark spots, improving skin clarity and uneven skin tone and preventing discolouration. In brief, it reduces the concentration of critical enzymes crucial for the melanogenesis process.
This unique combination of active ingredients work together to support the skin’s natural surface cell turnover, deeply hydrate, and reduce the appearance of fine lines for a more luminous complexion.
Lightweight and easily absorbed, the serum can be used twice daily all over the face or applied as a targeted treatment to problem areas where dark spots or scars are most prominent.
The CLINICCARE X3M Glow Booster is suitable for all skin types and tones, making it an ideal solution for anyone seeking to address pigmentation concerns and achieve a healthier, more glowing appearance.
The CLINICCARE X3M Glow Booster is now available for purchase.
Find out more here.
